LEO Pharma Unveils Major Breakthrough In Psoriasis Management

LEO Pharma has at the EADV Conference in Paris unveiled a new weapon in its long-running campaign to improve psoriasis management and treatment outcomes. However, the weapon is not a new drug but a ground-breaking computer-modelling tool, designed to help those involved in the assessment, planning and provision of psoriasis treatment in primary care to balance optimum outcomes with the growing need for cost control.

More: continued here

Filed under: Dermatology on September 30th, 2008